AEST.MED.INT.HLD.SP.ADR/3 (3FMA) — Strategic Asset Allocation Index
AEST.MED.INT.HLD.SP.ADR/3 (3FMA) has a Strategic Asset Allocation Index of 0.0% as of December 2023. Strategic assets (PP&E of €- plus long-term investments of €0.00) total €0.00, measured against net assets of €33.63 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See AEST.MED.INT.HLD.SP.ADR/3 balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
AEST.MED.INT.HLD.SP.ADR/3 Strategic Asset Allocation Index (2023–2023)
This chart shows how AEST.MED.INT.HLD.SP.ADR/3's Strategic Asset Allocation Index has evolved across 1 annual periods from 2023 to 2023. As of December 2023, the index stands at 0.0%, representing strategic assets of €0.00 against net assets of €33.63 Million EUR. For live market cap and overall valuation, see AEST.MED.INT.HLD.SP.ADR/3 stock valuation.
Annual Strategic Asset Allocation Index for AEST.MED.INT.HLD.SP.ADR/3 (2023–2023)
The table below presents the year-by-year Strategic Asset Allocation Index for AEST.MED.INT.HLD.SP.ADR/3 from 2023 to 2023, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See what is AEST.MED.INT.HLD.SP.ADR/3's book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 0.0% | €0.00 | €- | €0.00 | €33.63 Million | — |